Upload
jayson-tyler
View
213
Download
0
Tags:
Embed Size (px)
Citation preview
Pathology Visions Conference
Giri Iyer
General Manager, Strategic Development
Integrated IT Solutions
10/22/2007
Digital Pathology
HCIT Visions – A GE Healthcare Perspective
3GE Healthcare IITS
July 24, 2007
A Tale of Two Cities…
Pre-Clinical Research
Clinical Care Delivery
Patient Safety: Need better Tox data earlier
Drug Efficacy: Need better biomarkers and ADME profiles
Patient Safety : Five Rights Checking
Drug Efficacy: Need better drugs
Clinical Trial Process
Drug Candidate Funnel weak
Drug Costs and Failure Rates
Lost in Translation: Need better data exchange earlier
4GE Healthcare IITS
July 24, 2007
From Quasi-quantitativeTo Dynamic Range
From Single Biomarker To Multiplexing
From Dx To enabling Rx
To DigitalFrom Glass
The Future of Anatomical Pathology
5GE Healthcare IITS
July 24, 2007
Market Adoption Projection
Rx adopting
first;AMCs for Research
only
Ref Labs driving clinical;
AMCs for Clinical
Main stream clinical
adoption
2008-2009
2009-2010
2010+ Time
Market Access
• Scan times
•Image Quality
•Latency
• FDA approval
•Workflow
•Algorithms
•Workflow
•ROI story
• TCO story
6GE Healthcare IITS
July 24, 2007
Key Drivers for Industry Success• Whole slide Imaging today.. In vivo
molecular imaging tomorrow
• Better standards for Interoperability…DICOM, Jpeg, HL7, CDISC, MIMIx?, MIAPE?
• FDA compliance vs speed-to-market trade-offs
• Better Data Exchange…Fusion between Medical Informatics and Bio Informatics
• Ultimate litmus test is Drug Efficacy that is concomitant with Patient Safety
7GE Healthcare IITS
July 24, 2007
GE HCIT Perspective • Industry evolution driven through image digitization
• When its about fast scan times and high resolution images.. GE is a usual suspect
• Industry definitions changing? Is it a PACS? Is it a LIS? Is it just the old Anatomic Pathology Module on new
steroids?
• Interoperability with existing systems is key to success
• Customer acceptance will depend upon transforming Pathology workflow with significant value added
• Thanks for having us here.. The youngest start-up in the market… much to learn